http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021522279-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
filingDate 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021522279-A
titleOfInvention Tetrazole Containing Apoptosis Signaling Kinase 1 Inhibitor and How to Use It
abstract The present invention is a compound of formula (I) [Chemical formula 1] that inhibits apoptosis signal regulatory kinase 1 (ASK-1) associated with autoimmune disease, neurodegenerative disease, inflammatory disease, chronic renal disease, and cardiovascular disease. , And their pharmaceutically acceptable salts and esters. The present invention further relates to pharmaceutical compositions containing the aforementioned compounds for administration to subjects suffering from ASK-1 related diseases. The present invention also relates to a method of treating an ASK-1-related disease in a subject by administering a pharmaceutical composition comprising the compound of the present invention. The present invention relates specifically to methods of treating ASK-1 associated with hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
priorityDate 2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146764307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430670807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407629455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152983719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411428756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163697056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148818907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146965626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66509441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163869960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431879906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407439784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163908308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425899700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147577363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53806843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419106058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425363808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465350760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413792263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465794828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407033693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146225346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408682415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164002358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163905855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417249452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415001264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152844609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146225370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465657159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465653535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135376127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425077667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467190896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147059169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427747080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465601067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146225336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123157846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412008798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149492964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467368012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467368011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425781181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54772420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153244256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455664246

Total number of triples: 110.